DE165897C - - Google Patents
Info
- Publication number
- DE165897C DE165897C DENDAT165897D DE165897DA DE165897C DE 165897 C DE165897 C DE 165897C DE NDAT165897 D DENDAT165897 D DE NDAT165897D DE 165897D A DE165897D A DE 165897DA DE 165897 C DE165897 C DE 165897C
- Authority
- DE
- Germany
- Prior art keywords
- benzyl
- parts
- acid
- solution
- isovalerate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 claims description 21
- HVJKZICIMIWFCP-UHFFFAOYSA-N Benzyl 3-methylbutanoate Chemical compound CC(C)CC(=O)OCC1=CC=CC=C1 HVJKZICIMIWFCP-UHFFFAOYSA-N 0.000 claims description 16
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 claims description 10
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 claims description 9
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 claims description 8
- 235000019445 benzyl alcohol Nutrition 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 2
- 238000000034 method Methods 0.000 claims description 2
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 12
- 238000006243 chemical reaction Methods 0.000 description 6
- 150000002148 esters Chemical class 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 description 2
- 229940073608 benzyl chloride Drugs 0.000 description 2
- 238000004508 fractional distillation Methods 0.000 description 2
- 239000005457 ice water Substances 0.000 description 2
- AOJFQRQNPXYVLM-UHFFFAOYSA-N pyridin-1-ium;chloride Chemical compound [Cl-].C1=CC=[NH+]C=C1 AOJFQRQNPXYVLM-UHFFFAOYSA-N 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 230000001624 sedative effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 229940070710 valerate Drugs 0.000 description 2
- 229940005605 valeric acid Drugs 0.000 description 2
- FREZLSIGWNCSOQ-UHFFFAOYSA-N 3-methylbutanoyl 3-methylbutanoate Chemical compound CC(C)CC(=O)OC(=O)CC(C)C FREZLSIGWNCSOQ-UHFFFAOYSA-N 0.000 description 1
- ISULZYQDGYXDFW-UHFFFAOYSA-N 3-methylbutanoyl chloride Chemical compound CC(C)CC(Cl)=O ISULZYQDGYXDFW-UHFFFAOYSA-N 0.000 description 1
- XVMSFILGAMDHEY-UHFFFAOYSA-N 6-(4-aminophenyl)sulfonylpyridin-3-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=C(N)C=N1 XVMSFILGAMDHEY-UHFFFAOYSA-N 0.000 description 1
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- 125000001743 benzylic group Chemical group 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 210000001156 gastric mucosa Anatomy 0.000 description 1
- PSXRWZBTVAZNSF-UHFFFAOYSA-N hydron;quinoline;chloride Chemical compound Cl.N1=CC=CC2=CC=CC=C21 PSXRWZBTVAZNSF-UHFFFAOYSA-N 0.000 description 1
- XJTQJERLRPWUGL-UHFFFAOYSA-N iodomethylbenzene Chemical compound ICC1=CC=CC=C1 XJTQJERLRPWUGL-UHFFFAOYSA-N 0.000 description 1
- VYQSSWZYPCCBRN-HZSPNIEDSA-N menthyl isovalerate Chemical compound CC(C)CC(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C VYQSSWZYPCCBRN-HZSPNIEDSA-N 0.000 description 1
- 230000036629 mind Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- JJZAWYXASMCCLB-UHFFFAOYSA-M sodium;3-methylbutanoate Chemical compound [Na+].CC(C)CC([O-])=O JJZAWYXASMCCLB-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE165897C true DE165897C (enrdf_load_stackoverflow) |
Family
ID=431346
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT165897D Active DE165897C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE165897C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT165897D patent/DE165897C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DD148055A5 (de) | Verfahren zur herstellung von o-substituierten derivaten des(+)-cyanidan-3-ols | |
| DE2334262C3 (de) | N-(p-Chlor- bzw.Bromphenyl)-carbaminsäure-beta-phenoxyalkylester und Verfahren zu ihrer Herstellung | |
| DE165897C (enrdf_load_stackoverflow) | ||
| DE2220256A1 (de) | N-(o- bzw. p-nitrobenzoyl)-sulfoximine, verfahren zu ihrer herstellung und verwendung derselben | |
| DE1668896B2 (de) | Phenoxyalkancarbonsäuren ihre Salze und Ester und Verfahren zur Herstellung dieser Verbindungen | |
| DE2624177A1 (de) | Verfahren zur herstellung von m-benzoylhydratropsaeure | |
| DE522064C (de) | Verfahren zur Darstellung von Monoalkoxyaminobenzoesaeurealkaminestern | |
| DE2605650A1 (de) | Verfahren zur herstellung von para-isobutyl-phenylessigsaeurederivaten | |
| DE118537C (enrdf_load_stackoverflow) | ||
| DE2244179C3 (de) | D-threo-l-p-substituierte Phenyl-2dichloracetamidopropan-I.S-diol-ester, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel | |
| DE2263880A1 (de) | Verfahren zur aufspaltung eines cyclopentenolons in die optischen isomeren | |
| DE1298981B (de) | D-threo-1-Phenyl-2-amino-1, 3-propandiolderivate und Verfahren zu ihrer Herstellung | |
| US3884962A (en) | Phenylcarbamates | |
| AT205661B (de) | Verfahren zur Herstellung von Estern der Penicilline G und X | |
| AT223751B (de) | Verfahren zur Herstellung des neuen 18-O-Methylreserpsäuremethylesters | |
| DE414190C (de) | Verfahren zur Darstellung von Zitronensaeuretribenzylester | |
| DE252158C (enrdf_load_stackoverflow) | ||
| DE977519C (de) | Verfahren zur Herstellung von 1-Phenyl-2-dihalogenacetamino-1, 3-propandiolen | |
| DE69909960T2 (de) | Cyclopropylestern von Alfa-Tocopherol, Vitamin E Derivate und Verfahren zu deren Herstellung | |
| AT30315B (de) | Verfahren zur Darstellung von Diaminoalkylestern. | |
| DE1518329C (de) | Substituierte Mono , Di und Tn hydroxybenzylalkohole und Verfahren zu deren Herstellung | |
| CH660360A5 (de) | Verfahren zur herstellung von substituierten chloracetaniliden. | |
| AT208863B (de) | Verfahren zur Herstellung von rienem, kristallinem 3-Chlor-10-(3'-dimenthylaminopropyl)-phenthiazin | |
| DE881039C (de) | Verfahren zur Herstellung des Pentaerythrit-dichlorhydrin-monoschwefligsaeureesters | |
| DE1146883B (de) | Verfahren zur Herstellung von Dithiophosphinsaeureestern |